Rituximab Treatment: Uses, Dosage, and Side Effects Explained

Summary of Key Points

Rituximab is a prescription medication used to treat various conditions, including certain cancers and autoimmune diseases. It works by targeting specific immune cells. Rituximab is administered through intravenous (IV) infusion, with dosing schedules tailored to the condition being treated. Common side effects include infusion reactions and infections. Always consult your healthcare provider before starting or adjusting your dose.

Names of Medication

US Brand Name: Rituxan

Generic Name: Rituximab

The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. The generic name (Rituximab) is listed in parentheses.

Pharmacologic Category

Monoclonal Antibody

Antineoplastic Agent

Immunosuppressant

Rituximab Dosing and Administration

Rituximab is prescribed for several conditions in adults, with dosing schedules varying based on the specific condition being treated. Always consult your healthcare provider before making any changes to your dose. You can also schedule a telemedicine appointment with one of our providers for personalized advice.

Rituximab Dosage for Specific Conditions

1. Non-Hodgkin Lymphoma: 375 mg/m² IV once weekly for 4-8 weeks, depending on the type of lymphoma and treatment plan.
2. Chronic Lymphocytic Leukemia: 375 mg/m² IV on the first day, followed by 500 mg/m² IV on day 2 of each treatment cycle (every 28 days) for up to 6 cycles.
3. Rheumatoid Arthritis: 1000 mg IV on day 1 and day 15, followed by 1000 mg every 24 weeks or as needed based on symptoms.
4. Granulomatosis with Polyangiitis and Microscopic Polyangiitis: 375 mg/m² IV once weekly for 4 weeks, followed by maintenance therapy as directed by your healthcare provider.
5. Pemphigus Vulgaris: 1000 mg IV on day 1 and day 15, followed by 500 mg every 6 months or as needed based on disease activity.
6. Follicular Lymphoma: 375 mg/m² IV once weekly for 4-8 weeks, depending on the treatment plan.
7. Diffuse Large B-Cell Lymphoma: 375 mg/m² IV on day 1 of each chemotherapy cycle, typically every 21 days for 6-8 cycles.
8. Hodgkin Lymphoma: 375 mg/m² IV, typically administered with chemotherapy, with the exact schedule determined by your healthcare provider.
9. Idiopathic Thrombocytopenic Purpura: 375 mg/m² IV once weekly for 4 weeks.

Dosage Forms and Strengths

Rituximab is available in the following dosage forms:

1. Injection, solution: 100 mg/10 mL (10 mg/mL)
2. Injection, solution: 500 mg/50 mL (10 mg/mL)

Rituximab Infusion: Administration Instructions

Rituximab is administered as an intravenous (IV) infusion in a healthcare setting, typically in a hospital or clinic. The infusion process can take several hours, and patients are closely monitored for any reactions during and after the infusion. Your healthcare provider may pre-medicate you with antihistamines or corticosteroids to reduce the risk of infusion-related reactions. Follow all instructions provided by your healthcare team and report any side effects immediately.

Rituximab Side Effects and Adverse Reactions

Like all medications, Rituximab can cause side effects. Some are common and mild, while others may be more serious. Always consult your healthcare provider if you experience any side effects.

Common Rituximab Side Effects

1. Infusion Reactions: These may include fever, chills, rash, or difficulty breathing during or after the infusion. Most reactions occur during the first infusion.
2. Infections: Rituximab can weaken your immune system, increasing your risk of infections such as colds, sinus infections, or more serious infections like pneumonia.
3. Fatigue: Feeling unusually tired or weak is a common side effect.
4. Nausea: Some patients may experience nausea or an upset stomach after treatment.

Less Common and Rare Side Effects

1. Low Blood Cell Counts: Rituximab can lower white blood cells, red blood cells, or platelets, increasing the risk of infections, anemia, or bleeding.
2. Severe Skin Reactions: In rare cases, Rituximab can cause serious skin reactions, including blistering or peeling. Contact your healthcare provider immediately if you notice any severe skin changes.
3. Heart Problems: Some patients may experience chest pain, irregular heartbeats, or other heart-related issues. Seek medical attention if you experience any heart-related symptoms.

Contraindications for Rituximab Treatment

A contraindication is a specific condition where a medication should not be used because it may be harmful. For Rituximab, several contraindications should be considered before starting treatment. Discuss your medical history with your healthcare provider to ensure Rituximab is safe for you.

Key Contraindications for Rituximab

1. Active Infections: Rituximab can weaken your immune system, making it harder to fight infections. If you have an active infection, taking Rituximab could worsen it or make it harder to treat.
2. Severe Allergic Reactions to Rituximab or Its Components: If you’ve had a severe allergic reaction (anaphylaxis) to Rituximab or any of its ingredients, it is unsafe to take this medication again. Allergic reactions may include difficulty breathing, swelling, or severe rash.
3. Hepatitis B Infection: Rituximab can reactivate hepatitis B in individuals with a history of the infection, potentially leading to serious liver damage or failure. Your healthcare provider will likely test you for hepatitis B before starting Rituximab.
4. Severe Heart Conditions: Rituximab can cause heart-related side effects, such as irregular heartbeats or chest pain. If you have a history of severe heart disease, such as congestive heart failure or arrhythmias, Rituximab may not be safe for you.

Drug to Drug Interactions

Rituximab can interact with other medications, potentially increasing side effects or altering their effectiveness. It’s important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Some medications that may interact with Rituximab include:

1. Immunosuppressants: Drugs such as methotrexate (Trexall), azathioprine (Imuran), and mycophenolate mofetil (Cellcept) may increase the risk of infections when used alongside Rituximab.
2. Live vaccines: Vaccines like the measles, mumps, and rubella (MMR) vaccine or the varicella (chickenpox) vaccine should be avoided during Rituximab treatment, as your immune system may not respond effectively.
3. Blood pressure medications: Certain blood pressure medications, such as ACE inhibitors (e.g., lisinopril), may raise the risk of low blood pressure during Rituximab infusions.

Rituximab in Pregnancy

Is it Safe to Take Rituximab During Pregnancy?

Rituximab is generally not recommended during pregnancy unless the potential benefits outweigh the risks. It can cross the placenta and may affect the developing immune system of the fetus. If you are pregnant or planning to become pregnant, it’s essential to discuss the risks and benefits of Rituximab treatment with your healthcare provider. They may suggest alternative treatments or closely monitor your pregnancy if Rituximab is deemed necessary.

Rituximab While Breastfeeding

Is it Safe to Take Rituximab While Breastfeeding?

Rituximab is typically not recommended while breastfeeding. Although it is unclear whether Rituximab passes into breast milk, it is a large protein that could potentially impact the baby’s immune system. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to weigh the risks and benefits of continuing Rituximab treatment. They may recommend alternative therapies or advise you to stop breastfeeding while on Rituximab.

Estimated Cost of Rituximab

The cost of Rituximab can vary depending on your location and pharmacy. Without insurance, a 30-day supply using a GoodRX coupon may range from $1,000 to $3,000. This can be a significant financial burden, so it’s important to discuss your options with your healthcare provider or pharmacist. Financial assistance programs may be available to help reduce the cost of treatment.

Possible Alternatives to Rituximab

Depending on your condition, alternative medications or lifestyle changes may help manage your symptoms. Always consult your healthcare provider before making any changes to your treatment plan. Some possible alternatives for conditions commonly treated with Rituximab include:

1. Non-Hodgkin lymphoma: Alternatives include chemotherapy regimens like CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) or targeted therapies such as ibrutinib (Imbruvica). Radiation therapy may also be an option.
2. Chronic lymphocytic leukemia: Alternatives include ibrutinib (Imbruvica), venetoclax (Venclexta), or chemotherapy combinations like FCR (fludarabine, cyclophosphamide, and rituximab).
3. Rheumatoid arthritis: Other biologics such as adalimumab (Humira), etanercept (Enbrel), or tocilizumab (Actemra) may be considered. Lifestyle changes, including regular exercise, a balanced diet, and physical therapy, can also help manage symptoms.
4. Granulomatosis with polyangiitis and Microscopic polyangiitis: Alternatives include cyclophosphamide (Cytoxan) or methotrexate (Trexall). Corticosteroids like prednisone may also be used to control inflammation.
5. Pemphigus vulgaris: Corticosteroids and immunosuppressants such as azathioprine (Imuran) or mycophenolate mofetil (Cellcept) may serve as alternatives.
6. Follicular lymphoma: Chemotherapy regimens like CVP (cyclophosphamide, vincristine, and prednisone) or newer targeted therapies such as lenalidomide (Revlimid) may be considered.
7. Diffuse large B-cell lymphoma: Alternatives include chemotherapy regimens like R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) or CAR-T cell therapy.
8. Hodgkin lymphoma: Chemotherapy regimens like ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) or radiation therapy may be alternatives.
9. Idiopathic thrombocytopenic purpura: Alternatives include corticosteroids, intravenous immunoglobulin (IVIG), or thrombopoietin receptor agonists such as romiplostim (Nplate).

Always discuss these alternatives with your healthcare provider before making any changes to your treatment plan. If you have questions or need to consult a healthcare provider, you can schedule a telemedicine appointment with one of our providers today.

Recent Updates on Rituximab Research

Recent studies have explored Rituximab’s potential in treating additional autoimmune diseases, such as multiple sclerosis and lupus. Researchers are also investigating whether Rituximab can be combined with other therapies to enhance cancer treatment outcomes. Ongoing clinical trials are examining the long-term effects of Rituximab on the immune system and whether lower doses can reduce side effects. As new research emerges, stay informed and discuss any updates with your healthcare provider.

James Kingsley

Learn More